Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Sinopharm Group Co. Ltd. (X2S1.F)

Compare
10.50
-0.10
(-0.94%)
At close: April 4 at 8:13:02 AM GMT+2

Key Executives

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Wanyong Lian President & Executive Director -- -- 1971
Ms. Xiaojuan Li Chief Financial Officer -- -- 1976
Mr. Jinglin Sun Executive Director -- -- --
Mr. Yijian Wu VP, Secretary to the Board & Company Secretary -- -- 1970

Sinopharm Group Co. Ltd.

Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai, 200023
China
86 21 2305 2666 https://www.sinopharmgroup.com.cn
Sector: 
Healthcare
Full Time Employees: 
108,217

Description

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Corporate Governance

Sinopharm Group Co. Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 24, 2025 at 10:59 AM UTC - April 28, 2025 at 12:00 PM UTC

Sinopharm Group Co. Ltd. Earnings Date

Recent Events

June 18, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers